Safety & Evidence

Nootropics

Peptides

piracetam

racetams

safety

Understanding Nootropics Side Effects: Risks to Consider

Understanding Nootropics Side Effects: Risks to Consider

Authors and reviewers

Dr. Dimitar Marinov (MD, Ph.D.)

is a physician and dietitian practicing evidence-based medicine. He graduated in Medicine with honors in 2017 and completed his specialty training in Nutrition and Dietetics in 2023. His professional focus includes clinical nutrition, dietetics, and the application of scientific evidence in medical practice.

Nootropics is a broad term that can include a wide range of different compounds, each with its specific potential effects and risks. Examples include:

  • Prescription drugs & regulated medications used off-label
  • Supplements
  • Research peptides.

The side effects depend on specific compounds, the dose, the pattern of use (single use vs. daily), co-use with other substances like caffeine, alcohol, stimulants, etc. Moreover, another important factor is the user’s baseline risks like anxiety, hypertension, arrhythmias, liver disease, etc.

Therefore, it is important that you consult a qualified healthcare provider before adding any supplement or other nootropic to your routine. Nevertheless, below, you will discover the most common risks to consider, depending on the class of nootropics.

Wakefulness agents used off-label for cognition (modafinil and armodafinil)

Across trial datasets, the most consistently reported adverse effects with modafinil-class drugs are headache, insomnia, anxiety or nervousness, nausea, dizziness, and diarrhea. 

For example, a 2025 systematic review and meta-analysis that stratified by indication reported substantially higher relative risks for insomnia and anxiety/nervousness versus placebo in several groups and elevated risk for headache and nausea in some settings [1].

These drugs can also produce less common but clinically important reactions. Product labeling and pharmacovigilance emphasize stopping and seeking medical care for rash or hypersensitivity symptoms because severe cutaneous reactions, while rare, are a known risk category for this class [2].

If modafinil is used to extend wake time, insomnia and reduced sleep duration often follow, and that combination commonly amplifies anxiety, irritability, headache frequency, and next-day cognitive fog, which can be sometimes viewed as additional side effects.

Prescription stimulants (methylphenidate and amphetamine derivatives)

Stimulants predictably push sympathetic physiology. For example, a large 2025 meta-analysis across patient populations found increased risks of appetite loss and sleep disturbances, and it reinforces the pattern seen across many trials, such as small average increases in heart rate and blood pressure, with individual variability [3]. 

Moreover, another 2025 review focused on methylphenidate safety summarizes typical increases on the order of about 2-4 mmHg in blood pressure and about 3-6 beats/min in heart rate in many settings, usually not clinically important for healthy people, but more relevant in those with cardiovascular disease or risk factors [4].

The highest-risk patterns are:

  • Combining stimulants with high caffeine or decongestants and using them during prolonged sleep restriction may increase the risk of tachycardia, anxiety, panic symptoms, and insomnia, which then feeds back into impaired cognition and mood.
  • At higher doses or in susceptible individuals, transient psychotic symptoms and seizures are reported.

Nicotine, caffeine and caffeine stacks

Caffeine is the most common cognitive enhancer in practice, and most adverse effects depend on the dose and the timing. The most common ones are:

  • anxiety
  • tremor
  • reflux
  • tachycardia
  • insomnia

The good news is that L-theanine can be added to blunt the potential negative reactions. For example, several controlled studies suggest that L-theanine can attenuate the blood pressure increase seen under stress in high stress-response adults [5]. 

Notably, a placebo-controlled study combining L-theanine with caffeine reported that the combination at tea-like ratios eliminated a vasoconstrictive effect of caffeine in that experimental setup [6].

These findings do not mean L-theanine “cancels” caffeine side effects. If caffeine is taken at a high dose or late in the day, insomnia is often the main driver of next-day irritability, headache, and poor concentration. Nicotine is also considered nootropic as it can improve alertness in the short term, but it has an adverse event profile that is well-characterized. 

A systematic review and meta-analysis of 120 studies involving 177,390 individuals reported increased risks of palpitations and chest pains, nausea and vomiting, GI complaints, and insomnia with nicotine replacement compared with controls [7].

Other supplements 

Other than caffeine, there are a few natural supplements that may have potent nootropic effects worth exploring, such as Bacopa monieri and Ginkgo Biloba.

Across human trials and safety summaries, bacopa’s adverse effects are mainly gastrointestinal. A 2023 clinical study in adults reported that bacopa was generally well tolerated, with some participants discontinuing early due to reversible GI side effects such as nausea and diarrhea [8]. Side effects are usually minor and short-lived and commonly include abdominal pain, nausea, diarrhea, flatulence, dry mouth, headache, dizziness, insomnia, and rash, with adverse event rates often similar to placebo in trials. 

On the other hand, the main safety issue with ginkgo is interaction risk, especially with antiplatelet drugs, anticoagulants, and NSAIDs, because the clinical question is bleeding. A 2025 PLOS One analysis of ginkgo drug interactions reported frequent co-use signals with antiplatelets and NSAIDs and assessed bleeding and coagulation profiles in those combinations [9]. 

It appears that standardized ginkgo extracts measurably alter hemostasis parameters linked to bleeding risk, reflecting that this is the primary safety concern to address. Thus, Ginkgo is a supplement that warrants medication review, especially before surgery and in anyone using aspirin, clopidogrel, warfarin, DOACs, or frequent NSAIDs.

Racetams, piracetam-like compounds and research molecules

Racetams
Racetams — A class of synthetic nootropics (e.g., Piracetam, Phenyilpiracetam) known for improving memory and learning. Go to Glossary
are some of the most popular nootropic compounds. They are frequently described as well tolerated, with minor adverse effects reported in the literature, such as insomnia, agitation, irritability, and other central stimulatory effects in some groups [10]. You can read more about piracetam side effects in this article.

Other less-studied research compounds include research peptides, such as Semax. The published human data that are easy to access and verify are limited compared with mainstream prescription drugs, but available clinical reports describe Semax as being well tolerated with a low rate of side effects, including in older patients [11]. 

The main limitation is not a clear signal of frequent serious adverse events but the small number of well-described, widely replicated human studies and the fact that much of the clinical literature is region-specific and not synthesized in large, high-quality reviews. 

Are Nootropics Safe?

A smart nootropics approach is not about chasing the strongest effect but about choosing the best-studied option for your goal and using it in a way that respects dose, timing, and interactions. Most unwanted effects are predictable and often avoidable (especially sleep disruption, overstimulation, and GI upset), and they tend to improve when people simplify their stack and stop treating stimulants as a substitute for rest. If you have medical conditions or take regular medications, a brief check-in with a clinician can help you stay on the safer side while you explore what actually works for you.

References

    1. Jung J. et al. Assessing Condition-Specific Adverse Event Profiles of Modafinil for Labelled and Off-Label Uses: A Systematic Review and Meta-Analysis. Basic Clin Pharmacol Toxicol. 2026.

    1. Chapman JL, et al. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis. Eur Respir J. 2016.

    1. Oliva HNP, et al. Safety of Stimulants Across Patient Populations: A Meta-Analysis. JAMA Netw Open. 2025.

    1. Silczuk A, et al. Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults – narrative review. Pharmacol Rep. 2025

    1. Yoto A, et al. Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. J Physiol Anthropol. 2012.

    1. Dodd FL, et al. A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood. Psychopharmacology (Berl). 2015.

    1. Mills EJ, Wu P, Lockhart I, et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. 2010. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-. 

    1. Keegan AP, et al. Bacopa monnieri supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjects. J Clin Transl Res. 2023.

    1. Mai NTQ, et al. Impact of Ginkgo biloba drug interactions on bleeding risk and coagulation profiles: A comprehensive analysis. PLoS One. 2025.

    1. Malík M, Tlustoš P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. 2022.

    1. Gusev EI, Skvortsova VI, Chukanova EI. [Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency]. Zh Nevrol Psikhiatr Im S S Korsakova. 2005.

See comments

0

Share your thoughts

Thinking of something we should add? Send us your ideas-we’re listening!

By submitting my information, I agree to the Privacy Policy and Terms of Service .

Content is for informational purposes only and is not medical advice. Statements are not evaluated by the FDA or EMA. Always consult your healthcare provider.